Jeffrey A. Altman

Sits on 1 board. Last updated September 27, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: Anterix Inc., 2 years.

Anterix Inc. Director
2 years ยท Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 4, 2026 Anterix Inc. Grant or award +1,598 โ€” โ€”
Aug 5, 2025 Anterix Inc. Grant or award +7,767 โ€” โ€”
Dec 5, 2024 Anterix Inc. Grant or award +5,002 โ€” โ€”
Feb 8, 2024 Anterix Inc. Grant or award +2,647 โ€” โ€”
Dec 1, 2023 Anterix Inc. Open-market purchase +6,407 $33.41 $214,058
Dec 1, 2023 Anterix Inc. Open-market purchase +38,058 $33.99 $1,293,591
Nov 30, 2023 Anterix Inc. Open-market purchase +29,727 $32.11 $954,534
Nov 29, 2023 Anterix Inc. Open-market purchase +50,000 $32.15 $1,607,500
Sep 29, 2023 Estrella Immunopharma Inc. Other โˆ’255,000 $10.86 $2,769,300
Aug 11, 2023 OneMedNet Corp Other โˆ’465,000 $11.13 $5,175,450
Mar 20, 2023 Zura Bio Limited Other โˆ’550,000 $10.40 $5,720,000

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.